- Home
- RMR vs ANNX Comparison
RMR vs ANNX Comparison
Compare RMR & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMR
- ANNX
- Stock Information
- Founded
- RMR 1986
- ANNX 2011
- Country
- RMR United States
- ANNX United States
- Employees
- RMR N/A
- ANNX N/A
- Industry
- RMR Professional Services
- ANNX Biotechnology: Pharmaceutical Preparations
- Sector
- RMR Consumer Discretionary
- ANNX Health Care
- Exchange
- RMR Nasdaq
- ANNX Nasdaq
- Market Cap
- RMR 275.3M
- ANNX 252.3M
- IPO Year
- RMR N/A
- ANNX 2020
- Fundamental
- Price
- RMR $16.40
- ANNX $2.38
- Analyst Decision
- RMR
- ANNX Strong Buy
- Analyst Count
- RMR 0
- ANNX 4
- Target Price
- RMR N/A
- ANNX $12.50
- AVG Volume (30 Days)
- RMR 109.6K
- ANNX 1.4M
- Earning Date
- RMR 07-31-2025
- ANNX 08-11-2025
- Dividend Yield
- RMR 11.04%
- ANNX N/A
- EPS Growth
- RMR N/A
- ANNX N/A
- EPS
- RMR 1.06
- ANNX N/A
- Revenue
- RMR $197,672,000.00
- ANNX N/A
- Revenue This Year
- RMR $323.25
- ANNX N/A
- Revenue Next Year
- RMR $1.07
- ANNX N/A
- P/E Ratio
- RMR $15.33
- ANNX N/A
- Revenue Growth
- RMR N/A
- ANNX N/A
- 52 Week Low
- RMR $13.48
- ANNX $1.29
- 52 Week High
- RMR $26.43
- ANNX $7.85
- Technical
- Relative Strength Index (RSI)
- RMR 64.06
- ANNX 54.28
- Support Level
- RMR $15.73
- ANNX $2.26
- Resistance Level
- RMR $16.60
- ANNX $2.81
- Average True Range (ATR)
- RMR 0.38
- ANNX 0.21
- MACD
- RMR 0.10
- ANNX -0.02
- Stochastic Oscillator
- RMR 90.27
- ANNX 45.68
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.